119 filings
424B5
RXRX
Recursion Pharmaceuticals Inc - Ordinary Shares
27 Jun 24
Prospectus supplement for primary offering
1:04pm
8-K
RXRX
Recursion Pharmaceuticals Inc - Ordinary Shares
27 Jun 24
Recursion Announces Proposed Offering of Class A Common Stock
8:16am
424B5
RXRX
Recursion Pharmaceuticals Inc - Ordinary Shares
26 Jun 24
Prospectus supplement for primary offering
4:01pm
8-K
RXRX
Recursion Pharmaceuticals Inc - Ordinary Shares
24 Jun 24
Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Its Download Day
8:02am
8-K
RXRX
Recursion Pharmaceuticals Inc - Ordinary Shares
7 Jun 24
Submission of Matters to a Vote of Security Holders
9:00am
DEFA14A
yvr 1xu8e5y18jr
24 May 24
Additional proxy soliciting materials
4:35pm
8-K
i4x29z wj6
24 May 24
Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
4:31pm
S-8
wxce9ggj9qs47jx
9 May 24
Registration of securities for employees
7:46pm
8-K
o39ro6 01npd
9 May 24
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
4:04pm
ARS
xck7s
23 Apr 24
Annual report to shareholders
5:29pm
DEFA14A
s6d37ud51 6l
23 Apr 24
Additional proxy soliciting materials
5:16pm
8-K
z7rfk0 dz3w4v
16 Apr 24
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
8:04am
8-K
1s3cno5f uat166r
27 Feb 24
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
4:09pm
8-K
kyonn54f75 1g7siq8nf
7 Feb 24
Departure of Directors or Certain Officers
4:56pm
8-K
arxpoj
31 Jan 24
Amendments to Articles of Incorporation or Bylaws
4:40pm
8-K
q8p 0jag6as
8 Jan 24
Regulation FD Disclosure
7:59am
8-K
9uwv9wwp8 hu628
20 Dec 23
Regulation FD Disclosure
8:01am